Advanz Pharma Overview
- Year Founded
-
1963
- Status
-
Private
- Employees
-
650
- Latest Deal Type
-
Debt - Acquisition
- (Upcoming)
- Financing Rounds
-
18
- Investments
-
19
Advanz Pharma General Information
Description
Operator of a global pharmaceutical company focused on specialty and hospital medicines in Europe and Canada. The company has broad expertise in several therapeutic areas including hepatology, gastroenterology, critical care, anti-infectives, endocrinology, oncology, and more broadly rare disease medicines, helping improve patients' lives by providing and enhancing the specialty, hospital, and rare disease medicines they depend on.
Contact Information
Website
www.advanzpharma.comCorporate Office
- Dashwood House
- 2nd Floor, 69 Old Broad Street
- London EC2M 1QS
- England, United Kingdom
Corporate Office
- Dashwood House
- 2nd Floor, 69 Old Broad Street
- London EC2M 1QS
- England, United Kingdom
Advanz Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Advanz Pharma Comparisons
Industry
Financing
Details
000000
000000
Advanz Pharma Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oncolytics Biotech | Corporation | Calgary, Canada | 00 | 00000 | 00000000 | 00000 |
| Takeda Pharmaceutical Company | Corporation | Tokyo, Japan | 00000 | 00.00 | 000000000 00 | 00.00 |
Advanz Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Advanz Pharma Patents
Advanz Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3521667-B1 | Seal for a structure of a rail vehicle | Active | 05-Feb-2018 | 0000000000 | |
| EP-3521667-A1 | Seal for a structure of a rail vehicle | Active | 05-Feb-2018 | 0000000000 | 0 |
| FR-3077613-B1 | Sealing for a rail vehicle structure | Active | 05-Feb-2018 | 0000000000 | |
| FR-3077613-A1 | Seal trim for a structure of a railway vehicle | Active | 05-Feb-2018 | 0000000000 | 0 |
| FR-2823918-A1 | Ground mounted retractable energy distribution terminal, uses compressed gas jack to raise distribution part above ground and manual pressure or motor to retract it | Pending | 24-Apr-2001 | H02B1/505 |
Advanz Pharma Executive Team (24)
| Name | Title | Board Seat |
|---|---|---|
| Steffen Wagner | Chief Executive Officer | |
| Adeel Ahmad | Chief Financial Officer | |
| Andreas Stickler | Chief Financial Officer | |
| Karl Belk | Chief Operating Officer | |
| Francesco Tallarico JD | Chief Legal Officer & Secretary |
Advanz Pharma Board Members (18)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 0000 00 | Self | Board Member | 000 0000 |
| 000000 0000000 | Self | Board Member | 000 0000 |
| 000 0000 | Nordic Capital | Board Member | 000 0000 |
Advanz Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Advanz Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Advanz Pharma Investments & Acquisitions (19)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bayer (Global Rights of Androcur) | 31-Mar-2024 | 0000000000 | Buildings and Property | ||
| Tostran | 17-Oct-2023 | 0000000000 | Pharmaceuticals | 00000 000 | |
| Sanofi (Hospital Anti-infective Portfolio) | 30-Sep-2022 | 0000000000 | Buildings and Property | ||
| Intercept (Subsidiaries and Operations in Europe, Canada and Non-US Markets) | 01-Jul-2022 | 0000000000 | 00000 | Buildings and Property | 0000000 0 |
| Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) | 01-Jul-2022 | Buyout/LBO | 00000 | Drug Discovery | 0000000 0 |
Advanz Pharma Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Amdipharm Mercury | Distributors (Healthcare) | London, United Kingdom | 2003 |
| Tostran | Pharmaceuticals | Tokyo, Japan |
Advanz Pharma ESG
Risk Overview
Risk Rating
Updated March, 01, 2024
31.1 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 16,009
Rank
Percentile
Pharmaceuticals
Industry
00 of 909
Rank
Percentile
Pharmaceuticals
Subindustry
00 of 446
Rank
Percentile
Advanz Pharma FAQs
-
When was Advanz Pharma founded?
Advanz Pharma was founded in 1963.
-
Who is the founder of Advanz Pharma?
Mark Thompson is the founder of Advanz Pharma.
-
Who is the CEO of Advanz Pharma?
Steffen Wagner is the CEO of Advanz Pharma.
-
Where is Advanz Pharma headquartered?
Advanz Pharma is headquartered in London, United Kingdom.
-
What is the size of Advanz Pharma?
Advanz Pharma has 650 total employees.
-
What industry is Advanz Pharma in?
Advanz Pharma’s primary industry is Pharmaceuticals.
-
Is Advanz Pharma a private or public company?
Advanz Pharma is a Private company.
-
What is Advanz Pharma’s current revenue?
The current revenue for Advanz Pharma is 000000.
-
How much funding has Advanz Pharma raised over time?
Advanz Pharma has raised $586M.
-
Who are Advanz Pharma’s investors?
Nordic Capital has invested in Advanz Pharma.
-
Who are Advanz Pharma’s competitors?
Oncolytics Biotech and Takeda Pharmaceutical Company are competitors of Advanz Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
